Reduction of 90-day mortality in patients with severe sepsis and septic shock by initiation of oral beta-blocker treatment and continuation of a previous beta-blocker therapy

Wauschkuhn S.; Fuchs C.; Scheer C.; Vollmer M.; Rehberg S.; Meissner K.; Hahnenkamp K.; Gruendling M.

首页> 外文期刊>Infection >Reduction of 90-day mortality in patients with severe sepsis and septic shock by initiation of oral beta-blocker treatment and continuation of a previous beta-blocker therapy

【24h】

Reduction of 90-day mortality in patients with severe sepsis and septic shock by initiation of oral beta-blocker treatment and continuation of a previous beta-blocker therapy

机译：通过开始口服β受体阻滞剂治疗和继续使用先前的β受体阻滞剂治疗，可降低严重败血症和败血性休克患者的90天死亡率

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Infection》 |2015年第1期|共1页
作者
Wauschkuhn S.; Fuchs C.; Scheer C.; Vollmer M.; Rehberg S.; Meissner K.; Hahnenkamp K.; Gruendling M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Reduction of 90-day mortality in patients with severe sepsis and septic shock by initiation of oral beta-blocker treatment and continuation of a previous beta-blocker therapy [J] . Wauschkuhn S., Fuchs C., Scheer C., Infection . 2015,第Suppla1期

机译：通过开始口服β受体阻滞剂治疗和继续使用先前的β受体阻滞剂治疗，可降低严重败血症和败血性休克患者的90天死亡率
2. Vitamin D deficiency at admission is not associated with 90-day mortality in patients with severe sepsis or septic shock: Observational FINNAKI cohort study [J] . Ala-Kokko Tero I., Mutt Shivaprakash J., Nisula Sara, Annals of medicine . 2016,第1a2期

机译：严重败血症或败血性休克患者入院时维生素D缺乏与90天死亡率无关：FINNAKI观察性队列研究
3. Hemodynamic response to beta-blockers in severe sepsis and septic shock: A review of current literature [J] . van Loon Lex M., van der Hoeven Johannes G., Lemson Joris Journal of critical care . 2019,第期

机译：严重脓毒症和脓毒症患者对β-嵌体的血流动力学反应：对当前文献的综述
4. Relation of heart rate variability to serum levels of C-reactive protein in patients with severe sepsis and septic shock [C] . Papaioannou V.P., Dragoumanis C.D., Pneumatikos I.P. Computers in Cardiology, 2009 . 2009

机译：严重败血症和败血性休克患者心率变异性与血清C反应蛋白水平的关系
5. Fluid bolus administration in early goal directed therapy treatment of severe sepsis and septic shock in the emergency department: predictors and outcomes [D] . Williams, Jennifer A. 2014

机译：在急诊科室进行的早期目标定向治疗严重脓毒症和脓毒性休克的液体推注给药：预测因素和结果
6. 90-day mortality of severe sepsis and septic shock is reduced by initiation of oral beta-blocker therapy and increased by discontinuation of a pre-existing beta-blocker treatment [O] . C Fuchs, C Scheer, S Wauschkuhn, 2015

机译：开始口服β-受体阻滞剂治疗可降低严重败血症和败血性休克的90天死亡率而终止已有的β-受体阻滞剂治疗可增加90天死亡率
7. 90-DAY MORTALITY OF SEVERE SEPSIS AND SEPTIC SHOCK IS REDUCED BY INITIATION OF ORAL BETA-BLOCKER THERAPY AND INCREASED BY DISCONTINUATION OF A PRE-EXISTING BETA-BLOCKER TREATMENT [O] . C Fuchs, C Scheer, S Wauschkuhn, 2015

机译：口服贝他汀阻滞剂治疗可降低90％的严重脓毒症和震荡发作的死亡率，而不再使用已有的贝他汀阻滞剂治疗可增加90天死亡率

Reduction of 90-day mortality in patients with severe sepsis and septic shock by initiation of oral beta-blocker treatment and continuation of a previous beta-blocker therapy

著录项

相似文献

相关主题

期刊订阅